{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:33:15Z","timestamp":1791401595615,"version":"4.3.3"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008761","name":"StemCyte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.eclinm.2025.103737","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:48:47Z","timestamp":1768002527000},"page":"103737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"91","author":[{"given":"Yen-Wen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest Yin","family":"Lun Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lung-Kuo","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2025.103737_bib1","author":"Organization WH"},{"issue":"10453","key":"10.1016\/j.eclinm.2025.103737_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","article-title":"Long COVID: a clinical update","volume":"404","author":"Greenhalgh","year":"2024","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103737_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292672","article-title":"Long COVID in the United States","volume":"18","author":"Blanchflower","year":"2023","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103737_bib5","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection","volume":"28","author":"Al-Aly","year":"2022","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103737_bib6","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly","year":"2024","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103737_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300947","article-title":"The association between prolonged SARS-CoV-2 symptoms and work outcomes","volume":"19","author":"Venkatesh","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103737_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2023-000723","article-title":"Post-covid-19 conditions in adults: systematic review and meta-analysis of health outcomes in controlled studies","volume":"3","author":"Franco","year":"2024","journal-title":"BMJ Med"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103737_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2023.1933","article-title":"Understanding how Post-COVID-19 condition affects adults and health care systems","volume":"4","author":"Katz","year":"2023","journal-title":"JAMA Health Forum"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103737_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1186\/s12913-023-09601-6","article-title":"Long COVID: costs for the German economy and health care and pension system","volume":"23","author":"Gandjour","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103737_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240784","article-title":"Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection","volume":"15","author":"Townsend","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2025.103737_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.631008","article-title":"Emergent crisis of COVID-19 pandemic: mental health challenges and opportunities","volume":"12","author":"Radfar","year":"2021","journal-title":"Front Psychiatr"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103737_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/ijerph21030325","article-title":"From acute infection to prolonged health consequences: understanding health disparities and economic implications in long COVID worldwide","volume":"21","author":"Sweis","year":"2024","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103737_bib14","first-page":"31","article-title":"The effects of the COVID-19 pandemic on the mental health of workers and the associated social-economic aspects: a narrative review","volume":"74","author":"Wang","year":"2023","journal-title":"Work"},{"issue":"20","key":"10.1016\/j.eclinm.2025.103737_bib15","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","article-title":"Mechanisms of long COVID and the path toward therapeutics","volume":"187","author":"Peluso","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103737_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3947\/ic.2024.0024","article-title":"Updated Clinical Practice Guidelines for the diagnosis and management of long COVID","volume":"56","author":"Seo","year":"2024","journal-title":"Infect Chemother"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103737_bib17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jamainternmed.2024.2007","article-title":"Nirmatrelvir-ritonavir and symptoms in adults with postacute sequelae of SARS-CoV-2 infection: the STOP-PASC randomized clinical trial","volume":"184","author":"Geng","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.eclinm.2025.103737_bib18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.omtn.2023.08.016","article-title":"The current landscape of long COVID clinical trials: nih's RECOVER to Stanford Medicine's STOP-PASC initiative","volume":"33","author":"Chakraborty","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103737_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/npr2.12154","article-title":"Post-COVID-19 fatigue and anhedonia: a cross-sectional study and their correlation to post-recovery period","volume":"41","author":"El Sayed","year":"2021","journal-title":"Neuropsychopharmacol Rep"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103737_bib20","article-title":"Pooled prevalence of long COVID-19 symptoms at 12 months and above follow-up period: a systematic review and meta-analysis","volume":"15","author":"Mudgal","year":"2023","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103737_bib21","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.3390\/ijms24087445","article-title":"Oxidative damage and post-COVID syndrome: a cross-sectional study in a cohort of Italian workers","volume":"24","author":"Stufano","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.eclinm.2025.103737_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101946","article-title":"Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study","volume":"59","author":"Finnigan","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.eclinm.2025.103737_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106360","article-title":"Combining L-Arginine with vitamin C improves long-COVID symptoms: the LINCOLN survey","volume":"183","author":"Izzo","year":"2022","journal-title":"Pharmacol Res"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103737_bib24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jcyt.2020.04.100","article-title":"Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies","volume":"22","author":"Cancio","year":"2020","journal-title":"Cytotherapy"},{"key":"10.1016\/j.eclinm.2025.103737_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21037\/sci-2020-022","article-title":"Cellular therapy: shafts of light emerging for COVID-19","volume":"7","author":"Jeyaraman","year":"2020","journal-title":"Stem Cell Investig"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103737_bib26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/neurolint15030052","article-title":"Long COVID, the brain, nerves, and cognitive function","volume":"15","author":"Reiss","year":"2023","journal-title":"Neurol Int"},{"issue":"7907","key":"10.1016\/j.eclinm.2025.103737_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","article-title":"SARS-CoV-2 is associated with changes in brain structure in UK biobank","volume":"604","author":"Douaud","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103737_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41514-023-00118-0","article-title":"Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach","volume":"9","author":"Fonseca","year":"2023","journal-title":"NPJ Aging"},{"key":"10.1016\/j.eclinm.2025.103737_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.570282","article-title":"Umbilical cord blood transplants: current status and evolving therapies","volume":"8","author":"Gupta","year":"2020","journal-title":"Front Pediatr"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103737_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbmt.2016.01.020","article-title":"To match or not to match in cord blood transplantation: a modern look at a recurring question","volume":"22","author":"Kurtzberg","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103737_bib31","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neurobiolaging.2010.03.024","article-title":"Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation","volume":"33","author":"Lee","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103737_bib32","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s13287-022-03153-y","article-title":"Human umbilical cord blood mononuclear cells transplantation for perinatal brain injury","volume":"13","author":"Xi","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103737_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29757","article-title":"Human umbilical cord-derived mesenchymal stem cell transplantation improves the long COVID","volume":"96","author":"Tang","year":"2024","journal-title":"J Med Virol"},{"key":"10.1016\/j.eclinm.2025.103737_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/09636897211067447","article-title":"Complete restoration of motor function in acute cerebral stroke treated with allogeneic human umbilical cord blood monocytes: preliminary results of a phase I clinical trial","volume":"30","author":"Lee","year":"2021","journal-title":"Cell Transplant"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103737_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0292928","article-title":"Post-COVID-19 syndrome: physical capacity, fatigue and quality of life","volume":"18","author":"Beyer","year":"2023","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103737_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0022-3999(93)90081-P","article-title":"Development of a fatigue scale","volume":"37","author":"Chalder","year":"1993","journal-title":"J Psychosom Res"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103737_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3999(97)00291-2","article-title":"Fatigue in the general Norwegian population: normative data and associations","volume":"45","author":"Loge","year":"1998","journal-title":"J Psychosom Res"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2025.103737_bib38","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/oem.60.suppl_1.i1","article-title":"Fatigue at work","volume":"60 Suppl 1","author":"Van Dijk","year":"2003","journal-title":"Occup Environ Med"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103737_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpsychores.2009.10.007","article-title":"Measuring fatigue in clinical and community settings","volume":"69","author":"Cella","year":"2010","journal-title":"J Psychosom Res"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103737_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02982161","article-title":"The I.A.N.A task force on frailty assessment of older people in clinical practice","volume":"12","author":"Abellan van Kan","year":"2008","journal-title":"J Nutr Health Aging"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103737_bib41","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jval.2019.02.009","article-title":"United States valuation of EQ-5D-5L health states using an international protocol","volume":"22","author":"Pickard","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.eclinm.2025.103737_bib42","article-title":"SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability","author":"Crunfli","year":"2021","journal-title":"medRxiv"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103737_bib43","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1111\/ene.14803","article-title":"Neurological outcome and quality of life 3 months after COVID-19: a prospective observational cohort study","volume":"28","author":"Rass","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.eclinm.2025.103737_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","article-title":"Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis","volume":"101","author":"Ceban","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103737_bib45","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/jamaneurol.2020.2065","article-title":"Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review","volume":"77","author":"Zubair","year":"2020","journal-title":"JAMA Neurol"},{"issue":"773","key":"10.1016\/j.eclinm.2025.103737_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ado2106","article-title":"Translating insights into therapies for long covid","volume":"16","author":"Antar","year":"2024","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103737_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi9379","article-title":"Spontaneous, persistent, T cell-dependent IFN-gamma release in patients who progress to long covid","volume":"10","author":"Krishna","year":"2024","journal-title":"Sci Adv"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103737_bib48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/stcltm\/szad080","article-title":"A randomized, placebo-controlled, phase II trial of intravenous allogeneic non-HLA matched, unrelated donor, cord blood infusion for ischemic stroke","volume":"13","author":"Laskowitz","year":"2024","journal-title":"Stem Cells Transl Med"},{"issue":"19","key":"10.1016\/j.eclinm.2025.103737_bib49","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1089\/scd.2015.0074","article-title":"Involvement of immune responses in the efficacy of cord blood cell therapy for cerebral palsy","volume":"24","author":"Kang","year":"2015","journal-title":"Stem Cell Dev"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103737_bib50","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3727\/096368916X691411","article-title":"Phase I-II clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury","volume":"25","author":"Zhu","year":"2016","journal-title":"Cell Transplant"},{"issue":"1\u20132","key":"10.1016\/j.eclinm.2025.103737_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/pr.2017.236","article-title":"Umbilical cord blood cells for treatment of cerebral palsy; timing and treatment options","volume":"83","author":"McDonald","year":"2018","journal-title":"Pediatr Res"},{"key":"10.1016\/j.eclinm.2025.103737_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102146","article-title":"Long-term symptom severity and clinical biomarkers in post-COVID-19\/chronic fatigue syndrome: results from a prospective observational cohort","volume":"63","author":"Legler","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.eclinm.2025.103737_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.877772","article-title":"Molecular mechanisms of neuroinflammation in ME\/CFS and long COVID to sustain disease and promote relapses","volume":"13","author":"Tate","year":"2022","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103737_bib55","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s43587-024-00612-4","article-title":"Small extracellular vesicles from young plasma reverse age-related functional declines by improving mitochondrial energy metabolism","volume":"4","author":"Chen","year":"2024","journal-title":"Nat Aging"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103737_bib56","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/s43587-023-00451-9","article-title":"Multi-omic rejuvenation and life span extension on exposure to youthful circulation","volume":"3","year":"2023","journal-title":"Nat Aging"},{"key":"10.1016\/j.eclinm.2025.103737_bib57","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.12688\/f1000research.11437.1","article-title":"Therapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease","volume":"6","author":"Horowitz","year":"2017","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103737_bib58","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","article-title":"Aging and aging-related diseases: from molecular mechanisms to interventions and treatments","volume":"7","author":"Guo","year":"2022","journal-title":"Signal Transduct Target Ther"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025006728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025006728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:20:21Z","timestamp":1777634421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025006728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":56,"alternative-id":["S2589537025006728"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103737","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 StemCyte International, Ltd. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103737"}}